News Reports #2 from the 19th Congress of the European Hematology Association (Milan, Italy)

The 19th Congress of the European Hematology Association being held June 12 – 15 in Milan, Italy, the largest international hematology conference outside the United States, helps participating physicians to implement new research findings into their daily practice, making a tangible difference for their patients.

In the second of three EHA News Reports brought to you from Milan, we welcome:

  • Ali Taher, MD, FRCP, Professor of Medicine, Hematology & Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon, discusses the latest news on Red blood cells and iron,
  • Herv? Dombret, MD, Director, University Institute of Hematology, Director of the Clinical Research in Hematology, Immunology and Transplantation Unit at the University Paris Diderot, Paris, France, and Head of the Leukemia Unit, Department of Clinical Hematology/Immunology/Oncology H?pital Saint Louis, Paris, France, highlights several interesting presentations on Acute lymphoblastic leukemia or ALL, a malignant (clonal) disease of the bone marrow in which early lymphoid precursors proliferate and replace the normal hematopoietic cells of the marrow;
  • Alessandro Vannucchi, MD, Associate Professor of Hematology, University of Florence and Member of the Board of Doctorate School in Experimental and Clinical Oncology, University of Florence, Italy, focusses on various presentations around Myeloproliferative neoplasms (MPN), a related group of blood cancers in which the bone marrow cells that produce blood cells develop and function abnormally;
  • Michael Pfreundschuh, MD, PhD, Professor of Internal Medicine I, Saarland University Medical School, Homburg, Germany, discusses the latest news on Non-Hodgkin Lymphoma, which can be any of a large group of cancers of lymphocytes (white blood cells).

Copyright ? 2014 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.